Clinical Trials Directory

Phase II Study of Combination Stereotactic Body Radiotherapy (SBRT) With Transarterial Chemo-Embolization (TACE) for Unresectable Hepatocellular Carcinoma

To determine the efficacy and toxicity of TACE combined with SBRT

Stanford is not currently accepting new patients for this trial. You may want to check to see if other locations are recruiting.



  • procedure : SBRT
  • procedure : TACE

Phase: Phase 1/Phase 2


Ages Eligible For Study:

18 Years - N/A

External Links

Explore related trials

Contact information

Primary Contact:

Laurie Ann Columbo 650-736-0792

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: